Breast Cancer
Prostate Cancer
$103.30 ~
Zoladex 3.6 is a subcutaneous depot injection containing goserelin 3.6mg, a synthetic analogue of go...
Zoladex 3.6 is a subcutaneous depot injection containing goserelin 3.6mg, a synthetic analogue of gonadotropin-releasing hormone (GnRH). It provides reversible suppression of the hypothalamic-pituitary-gonadal (HPG) axis by initially stimulating, then downregulating, GnRH receptors. This leads to profound reductions in circulating sex hormones such as testosterone in men and estrogen in women, effectively mimicking the effects of surgical castration. Zoladex 3.6 is used in the palliative management of advanced prostate cancer and hormone receptor-positive breast cancer in premenopausal women. It is also indicated in several gynecologic conditions including endometriosis, uterine fibroids, and for ovulation suppression in assisted reproductive technologies like IVF. With its monthly dosing schedule and proven clinical efficacy, Zoladex 3.6 remains a cornerstone in hormone-sensitive oncologic and gynecologic therapy.
Show more
